Labor
deutsch englisch
Admo Award Bologna 2005
Publikationen Admo Logo

Preisverleihung des Ersten Internationalen ADMO Awards, Bologna 2005.

Beilhack A and Rockson SG. Immune Traffic: A Functional Overview. Lymphatic Research and Biology 1:219-234, 2003.

Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A. 101:221-226, 2004.

Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Baker EM, Herman EI, Cao YA, Contag CH, Negrin RS. In Vivo Analyses of Early Events in Acute Graft-versus-Host Disease Reveal Sequential Infiltration of T Cell Subsets. Blood 106(3):1113-22, 2005

Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ, Reeves R, Taylor-Edwards C, Schulz S, Doyle TC, Fathman CG, Robbins RC, Herzenberg LA, Negrin RS, Contag CH. Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80(1):134-139, 2005

Sato T, Habtezion A, Beilhack A, Schulz S, Butcher EC, Thorlacius H. Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host disease. Journal of Hepatology 44(6):1132-40, 2006

Zeiser R, Nguyen V, Beilhack A, Schulz S, Buess M, Baker J, Contag CH, Negrin RS. Inhibition of CD4+CD25+ regulatory T cell function by calcineurin dependent interleukin-2 production. Blood 108(1):390-9, 2006

Zeiser R, Beilhack A, Negrin RS. Acute graft-versus-host disease – Challenge for a broader application of allogeneic hematopoietic cell transplantation. Current Stem Cell Research and Therapy 1(2):203-212, 2006

Tabibiazar R, Cheung L, Swanson S, Han J, Beilhack A, An A, Wagner R, Rockson N, Shin WS, Rockson SG. Inflammatory manifestations of experimental lymphatic insufficiency: functional, histopathological and molecular characterization. PLOS Medicine 3(7):e254, 2006

Nguyen VH, Zeiser R, daSilva DL, Chang DS, Beilhack A, Contag CH, Negrin RS. In vivo dynamics of regulatory T cell trafficking and survival predict function in controlling GvHD following allogeneic transplantation. Blood 109(6):2649-56, 2007

Zeiser R, Nguyen V, Jing-Zhou H, Beilhack A, Zambricki E, Buess M, Contag CH, Negrin RS. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in the prevention of acute graft versus host disease. Blood 109(5):2225-33, 2007

Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, An A, Rockson SG. An experimental model for the study of lymphedema and its response to therapeutic lymphangiognesis. BioDrugs. 20(6):363-70, 2006

Fernandez I, Zeiser R, Karsunky H, Kambham N, Soderstrom K, Beilhack A, Negrin RS, Engleman EG. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J Immunol. 179(5):2808-14, 2007

Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood. 111(1):453-62, 2008

Beilhack A, Schulz S, Baker J, Beilhack GF, Nishimura R, Baker EM, Landan G, Herman EI, Butcher EC, Contag CH, Negrin RS. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood, 111(5):2919-28, 2008

Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Sega EI, Karimi M, Negrin RS. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of anti-tumor activity. Blood, in press. [Epub ahead of print]